Scarica l'app Stockscreener
1.20
7.14%
-0.0923
Precedente Chiudi:
$1.2923
Aprire:
$1.27
Volume 24 ore:
21,975
Relative Volume:
0.05
Capitalizzazione di mercato:
$2.77M
Reddito:
-
Utile/perdita netta:
$-9.60M
Rapporto P/E:
-0.3797
EPS:
-3.16
Flusso di cassa netto:
$-8.96M
1 W Prestazione:
-18.37%
1M Prestazione:
-20.53%
6M Prestazione:
-88.15%
1 anno Prestazione:
-85.61%
Intervallo 1D:
$1.18
$1.2777
Intervallo di 1 settimana:
$1.18
$1.5161
Portata 52W:
$1.15
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
Nome
Artelo Biosciences Inc
Settore
Industria
Telefono
858-925-7049
Indirizzo
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
Compare ARTL vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
1.20 | 2.99M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-08 | Aggiornamento | D. Boral Capital | Hold → Buy |
| 2021-02-12 | Iniziato | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc Borsa (ARTL) Ultime notizie
Artelo Biosciences Secures Flexible Multiyear Equity Financing - TipRanks
Artelo Biosciences Granted Nasdaq Extension to Regain Compliance - TipRanks
Artelo Biosciences Granted Nasdaq Compliance Extension - TradingView
Trade Recap: Is The TJX Companies Inc affected by consumer sentiment2025 Price Momentum & Weekly Top Performers Watchlists - baoquankhu1.vn
Artelo Biosciences Stockholders Approve Directors, Say-on-Pay and Auditor at 2025 Annual Meeting - Defense World
Why analysts upgrade Artelo Biosciences Inc. stockPortfolio Profit Report & AI Driven Stock Movement Reports - mfd.ru
Artelo Biosciences, Inc. (NASDAQ:ARTL) Given Average Rating of “Hold” by Brokerages - Defense World
Stock Analysis: Is Artelo Biosciences Inc impacted by rising ratesWeekly Trade Review & Accurate Intraday Trading Signals - baoquankhu1.vn
Can Constellation Brands Inc lead its sector in growthWeekly Risk Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Artelo Biosciences adjourns and reschedules 2025 annual meeting - MSN
Market Leaders: Is KORE attractive at current valuationJuly 2025 Outlook & Reliable Trade Execution Plans - baoquankhu1.vn
Artelo Biosciences faces new Nasdaq compliance challenges - The Globe and Mail
Artelo Biosciences Received Notice of Noncompliance - TradingView
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
How Artelo Biosciences Inc. stock reacts to inflationary pressuresDaily Trainer Picks & support options for steady strides - ulpravda.ru
Artelo Biosciences, Inc.Common Stock (NQ: ARTL - FinancialContent
D. Boral Capital Downgrades Artelo Biosciences (ARTL) - MSN
What makes Inno Holdings Inc. stock price move sharply - ulpravda.ru
Can Artelo Biosciences Inc. stock sustain free cash flow growthTrade Volume Report & Free Community Consensus Stock Picks - ulpravda.ru
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Is Artelo Biosciences Inc. stock a buy in volatile marketsJuly 2025 Technicals & Growth Focused Entry Point Reports - Улправда
Star TribuneArtelo Biosciences, Inc.Common Stock (Nasdaq:ARTL) Stock Quote - FinancialContent
How strong is Artelo Biosciences Inc. stock balance sheetCPI Data & Capital Protection Trading Alerts - ulpravda.ru
Artelo Biosciences Inc Stock Analysis and ForecastCandlestick Trading Patterns & Best Stocks For Explosive Growth - earlytimes.in
Artelo Biosciences, Inc. (NASDAQ:ARTL) Given Average Recommendation of “Hold” by Analysts - Defense World
Bank Watch: Can Artelo Biosciences Inc stock deliver 10 annual returnsQuarterly Market Summary & Reliable Price Breakout Alerts - moha.gov.vn
Is Artelo Biosciences Inc a good long term investmentAI-Driven Market Analysis & Explosive Growth Opportunities - earlytimes.in
Artelo Biosciences adjourns annual meeting due to lack of quorum - Investing.com
Artelo Biosciences Adjourns and Reschedules 2025 Annual Meeting - TipRanks
Artelo Biosciences adjourns annual meeting due to lack of quorum By Investing.com - Investing.com South Africa
Artelo Biosciences Adjourns and Reschedules Annual Meeting - TradingView — Track All Markets
Technical Analysis: How strong is Artelo Biosciences Inc stock balance sheetQuarterly Profit Report & Scalable Portfolio Growth Ideas - Bộ Nội Vụ
Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate - The Manila Times
Artelo Biosciences launches public offering; shares down 10% - MSN
Why Artelo Biosciences Inc. stock is favored by top institutionsTrade Volume Report & Free Expert Verified Stock Movement Alerts - Улправда
ARTL (Artelo Biosciences) EV-to-OCF : -0.31 (As of Dec. 22, 2025) - GuruFocus
Geopolitics Watch: Why Artelo Biosciences Inc. stock is favored by top institutions2025 Pullback Review & Free Safe Capital Growth Stock Tips - Улправда
Artelo Biosciences launches underwritten public offering to raise capital - MSN
Artelo Biosciences Earnings Notes - Trefis
Mark Edward Spring Net Worth (2025) - GuruFocus
Artelo Biosciences files to sell 899,972 shares of common stock for holders - MSN
Artelo Biosciences, Inc. (ARTL) 6.68% in After-hours: Following Strong Business Update - Stocks Telegraph
Artelo Biosciences Revises Bylaws, Alters Governance Structure - MSN
Artelo Biosciences (ARTL) Stock: Faces Market Reaction After Positive Research on Stress Relief Treatments - parameter.io
Unexpected Movements: Artelo Biosciences’ Stock Dynamics - timothysykes.com
Artelo Biosciences (ARTL) Research Highlights Potential of FABP5 Inhibitor in Stress Management - GuruFocus
Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of A Novel Fatty Acid Binding Protein 5 Inhibitor Significantly Reduces Stress-Induced Anxiety and Depression Behaviors in Preclinical Mod - marketscreener.com
Artelo (Nasdaq: ARTL) study: FABP5 inhibitor reduces anxiety, depression in rats - Stock Titan
Artelo Biosciences, Inc. (ARTL) -5.56% in After-hours: Stock Declines Amid Routine Trading - Stocks Telegraph
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Will Artelo Biosciences Inc. stock see insider buyingJobs Report & AI Driven Stock Movement Reports - Newser
Artelo Biosciences Inc Azioni (ARTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):